BlackRock Investment Management’s Inovio Pharmaceuticals INO Stock Holding History

BlackRock Investment Management’s Portfolio INO Stock Details INO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$1.79M	Sell	21,539 -77	-0.4%	-$6.96K	﹤0.01%	2286
2016 Q3	$2.42M	Sell	21,616 -43	-0.2%	-$4.75K	﹤0.01%	1997
2016 Q2	$2.4M	Sell	21,659 -116	-0.5%	-$14.1K	﹤0.01%	1965
2016 Q1	$2.28M	Buy	21,775 +472	+2%	+$36.4K	﹤0.01%	1902
2015 Q4	$1.72M	Sell	21,303 -40	-0.2%	-$3.19K	﹤0.01%	2190
2015 Q3	$1.48M	Sell	21,343 -192	-0.9%	-$16.7K	﹤0.01%	2291
2015 Q2	$2.11M	Buy	21,535 +6,651	+45%	+$711K	﹤0.01%	2187
2015 Q1	$1.46M	Buy	14,884 +185	+1%	+$17.9K	﹤0.01%	2257
2014 Q4	$1.62M	Sell	14,699 -221	-1%	-$27K	﹤0.01%	2191
2014 Q3	$1.76M	Buy	14,920 +196	+1%	+$24.4K	﹤0.01%	2091
2014 Q2	$1.91M	Buy	+14,724	New	+$1.74M	﹤0.01%	2102

Other funds holding INO

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

PAM

Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

BlackRock Investment Management's INO Position: Q4 2016 in Review

BlackRock Investment Management reduced its Inovio Pharmaceuticals (INO) stake by 0.36% in Q4 2016, selling an estimated $6.96K and leaving 21,539 shares worth $1.79M. The position accounts for ﹤0.01% of the portfolio, ranked #2286.

BlackRock Investment Management first reported a position in INO in Q2 2014 and has held it in 11 quarters since. The position peaked at $2.42M in Q3 2016. 125 funds tracked by Wall St. Rank hold INO as of Q4 2016.

BlackRock Investment Management held 21,539 shares of Inovio Pharmaceuticals worth $1.79M as of Q4 2016.
BlackRock Investment Management sold 77 Inovio Pharmaceuticals shares in Q4 2016, an estimated $6.96K.
Inovio Pharmaceuticals made up ﹤0.01% of BlackRock Investment Management's portfolio in Q4 2016, its #2286 holding.
BlackRock Investment Management first reported a position in Inovio Pharmaceuticals in Q2 2014 and has held it in 11 quarters since.
BlackRock Investment Management's Inovio Pharmaceuticals position peaked at $2.42M in Q3 2016.
125 funds tracked by Wall St. Rank held Inovio Pharmaceuticals as of Q4 2016.

Based on BlackRock Investment Management's 13F filing for Q4 2016, filed 10 Feb 2017.